MicroRNA-145 regulates oncolytic herpes simplex virus-1 for selective killing of human non-small cell lung cancer cells

Virology Journal

Volumn 10, Issue , 2013, Pages

  Li, Jhy Ming ^a,b   Kao, Kuo Chin ^a   Li, Li Fu ^a   Yang, Tsung Ming ^a   Wu, Chean Ping ^b   Horng, Yan Ming ^b   Jia, William Wg ^c   Yang, Cheng Ta ^a,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Lung cancer; MicroRNA; Oncolytic virus; Radiotherapy

Indexed keywords

MICRORNA 145; ONCOLYTIC HERPES VIRUS;

3' UNTRANSLATED REGION; AMPLICON; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RADIOTHERAPY; CELL KILLING; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION; GENE REPLICATION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; ONCOLYTIC VIROTHERAPY; VIRUS GENE; VIRUS REPLICATION;

3' UNTRANSLATED REGIONS; BINDING SITES; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CELL SURVIVAL; DNA, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; ONCOLYTIC VIRUSES;

HUMAN HERPESVIRUS 1;

EID: 84880334206     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-10-241     Document Type: Article

References (33)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2001 61 69 90
2. Drug resistance in lung cancer. Shanker M, Willcutts D, Roth JA, Ramesh R, Lung Cancer: Targets and Ther 2010 1 23 36
3. Drug resistance in non-small cell lung cancer. Monzo M, Rosell R, Taron M, Lung Cancer 2001 34 Suppl 2 91 S94 11742710
4. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Rodel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, Sauer R, Rodel C, Cancer Res 2005 65 4881 4887 10.1158/0008-5472.CAN-04-3028 15930309 (Pubitemid 40740827)
5. EGFR-TKI resistant non-small cell lung cancer (NSCLC): new developments and implications for future treatment. Brugger W, Thomas M, Lung Cancer 2012 77 2 8 10.1016/j.lungcan.2011.12.014 22281074
6. History of oncolytic viruses: genesis to genetic engineering. Kelly E, Russell SJ, Mol Ther 2007 15 651 659 17299401 (Pubitemid 46431984)
7. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer. Nettelbeck DM, J Mol Med (Berl) 2008 86 363 377 10.1007/s00109-007- 0291-1
8. Targeting gene-virotherapy of cancer. Liu XY, Gu JF, Cell Res 2006 16 25 30 10.1038/sj.cr.7310005 16467873 (Pubitemid 43129306)
9. Experimental therapy of human glioma by means of a genetically engineered virus mutant. Martuza RL, Malick A, Markert JM, Ruffner KL, Coen DM, Science 1991 252 854 856 10.1126/science.1851332 1851332 (Pubitemid 121000529)
10. Transcriptional targeting of herpes simplex virus for cell-specific replication. Miyatake S, Iyer A, Martuza RL, Rabkin SD, J Virol 1997 71 5124 5132 9188579 (Pubitemid 27258184)
11. Herpes simplex virus type-1 infection upregulates cellular promoters and telomerase activity in both tumor and nontumor human cells. Yang CT, Song J, Bu X, Cong YS, Bacchetti S, Rennie P, Jia WW, Gene Ther 2003 10 1494 1502 10.1038/sj.gt.3302005 12900765 (Pubitemid 36992161)
12. MicroRNAs: genomics, biogenesis, mechanism, and function. Bartel DP, Cell 2004 116 281 297 10.1016/S0092-8674(04)00045-5 14744438 (Pubitemid 38167318)
13. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Gregory R, Chendrimada TP, Cooch N, Shiekhattar R, Cell 2005 123 631 640 10.1016/j.cell.2005.10.022 16271387 (Pubitemid 41608466)
14. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Liu CG, Calin GA, Meloon B, Gamliel N, Sevignani C, Ferracin M, Dumitru CD, Shimizu M, Zupo S, Dono M, Alder H, Bullrich F, Negrini M, Croce CM, Proc Natl Acad Sci U S A 2004 101 9740 9744 10.1073/pnas.0403293101 15210942 (Pubitemid 38869306)
15. The functions of animal microRNAs. Ambros V, Nature 2004 431 350 355 10.1038/nature02871 15372042 (Pubitemid 39265675)
16. A microRNA expression signature of human solid tumors defines cancer gene targets. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM, Proc Natl Acad Sci U S A 2006 103 2257 2261 10.1073/pnas.0510565103 16461460 (Pubitemid 43271657)
17. Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. Hui A, How C, Ito E, Liu FF, BMC Cancer 2011 11 500 10.1186/1471-2407-11-500 22128797
18. MicroRNA-143 and -145 in colon cancer. Akao Y, Nakagawa Y, Naoe T, DNA Cell Biol 2007 26 311 320 10.1089/dna.2006.0550 17504027 (Pubitemid 46799180)
19. MicroRNA expression profiles in serous ovarian carcinoma. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S, Clin Cancer Res 2008 14 2690 2695 10.1158/1078-0432.CCR-07-1731 18451233
20. MicroRNA expression profiling in prostate cancer. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T, Cancer Res 2007 67 6130 6135 10.1158/0008-5472.CAN-07-0533 17616669 (Pubitemid 47037493)
21. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M, Seki N, Int J Cancer 2009 125 345 352 10.1002/ijc.24390 19378336
22. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Lee CY, Rennie PS, Jia WW, Clin Cancer Res 2009 15 5126 5135 10.1158/1078-0432.CCR-09-0051 19671871
23. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. Guan P, Yin Z, Li X, Wu W, Zhou B, J Exp Clin Cancer Res 2012 31 54 10.1186/1756-9966-31-54 22672859
24. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng A, Hu J, J Exp Clin Cancer Res 2010 29 151 10.1186/1756-9966-29-151 21092188
25. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. McCarthy AM, McMahan L, Schaffer PA, J Virol 1989 63 18 27 2535723 (Pubitemid 19028077)
26. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Cho WC, Chow AS, Au JS, Eur J Cancer 2009 45 2197 2206 10.1016/j.ejca.2009.04. 039 19493678
27. Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation. Spear MA, Sun F, Eling DJ, Gilpin E, Kipps TJ, Chiocca EA, Bouvet M, Cancer Gene Ther 2000 7 1051 1059 10.1038/sj.cgt.7700208 10917208 (Pubitemid 30483485)
28. Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer. Adusumilli PS, Stiles BM, Chan MK, Chou TC, Wong RJ, Rusch VW, Fong Y, Ann Thorac Surg 2005 80 409 416 discussion 416-417 10.1016/j.athoracsur.2005.01.048 16039175 (Pubitemid 41019451)
29. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck. Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y, Eur J Cancer 2005 41 313 322 10.1016/j.ejca.2004.10.018 15661558 (Pubitemid 40126965)
30. Radiation modulation of microRNA in prostate cancer cell lines. Josson S, Sung SY, Lao K, Chung LW, Johnstone PA, Prostate 2008 68 1599 1606 10.1002/pros.20827 18668526
31. Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake. Egami T, Ohuchida K, Mizumoto K, Onimaru M, Toma H, Nishio S, Nagai E, Matsumoto K, Nakamura T, Tanaka M, Clin Cancer Res 2008 14 1859 1867 10.1158/1078-0432.CCR- 07-0933 18347189 (Pubitemid 351469473)
32. Real-time quantification of microRNAs by stem-loop RT-PCR. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ, Nucleic Acids Res 2005 33 179 10.1093/nar/gni178 16314309 (Pubitemid 41806407)
33. Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells. Yang CT, Li JM, Weng HH, Li YC, Chen HC, Chen MF, Cancer Gene Ther 2010 17 120 130 10.1038/cgt.2009.55 19730451